Global X Genomics & Biotechnology ETF
Price through Nov 13, 2026 · Flows through Aug 23, 2024. Figures use the latest available records, not a live quote. Fund details retrieved Nov 15, 2026. Holdings snapshot retrieved Nov 15, 2026.
The fund invests at least 80% of its total assets in the securities of the underlying index. The underlying index is designed to provide exposure to exchange-listed companies that are positioned to benefit from further advances in the field of genomic science and biotechnology, as well as applications thereof (collectively, "Genomics & Biotechnology Companies"), as defined by Solactive AG, the provider of the underlying index. The fund is non-diversified.
GNOM price
Table
| Date | GNOM close |
|---|---|
| Oct 13, 2026 | $65.34 |
| Oct 14, 2026 | $65.91 |
| Oct 15, 2026 | $67.01 |
| Oct 16, 2026 | $64.31 |
| Oct 19, 2026 | $65.58 |
| Oct 20, 2026 | $67.65 |
| Oct 21, 2026 | $68.72 |
| Oct 22, 2026 | $66.01 |
| Oct 23, 2026 | $65.58 |
| Oct 26, 2026 | $66.46 |
| Oct 27, 2026 | $68.80 |
| Oct 28, 2026 | $71.51 |
| Oct 29, 2026 | $72.54 |
| Oct 30, 2026 | $69.61 |
| Nov 2, 2026 | $66.83 |
| Nov 3, 2026 | $68.01 |
| Nov 4, 2026 | $70.14 |
| Nov 5, 2026 | $63.98 |
| Nov 6, 2026 | $64.65 |
| Nov 9, 2026 | $67.34 |
| Nov 10, 2026 | $65.23 |
| Nov 11, 2026 | $65.14 |
| Nov 12, 2026 | $62.77 |
| Nov 13, 2026 | $61.67 |
Daily net flows, 1M
Net outflow over the range: −$0M
- Inflow / above zero
- Outflow / below zero
Show as table
| Label | Value ($) |
|---|---|
| Jul 23 | −$115.9K |
| Jul 24 | −$127.5K |
| Jul 25 | $200.9K |
| Jul 26 | −$73.9K |
| Jul 29 | $95.2K |
| Jul 30 | −$29.4K |
| Jul 31 | −$167.8K |
| Aug 1 | $48.8K |
| Aug 2 | $163.4K |
| Aug 5 | −$171.2K |
| Aug 6 | $197.9K |
| Aug 7 | −$243.9K |
| Aug 8 | $130K |
| Aug 9 | $48.6K |
| Aug 12 | $749.19 |
| Aug 13 | −$54.8K |
| Aug 14 | −$10.1K |
| Aug 15 | $26.2K |
| Aug 16 | $52.2K |
| Aug 19 | −$135.5K |
| Aug 20 | $157.1K |
| Aug 21 | −$140.8K |
| Aug 22 | $103.9K |
| Aug 23 | $0 |
Recent fund-flow records are unavailable, while the price has returned +35.7% so far this year. At 0.50% a year it is not the cheapest way in — IWM has a reported fee of 0.19%.
COMPOSED FROM THE FUND’S OWN DAILY RECORDS · UPDATED WITH EACH REFRESH
CELL SIZE IS PORTFOLIO WEIGHT · COLOR IS THE CHANGE IN THE LATEST AVAILABLE SNAPSHOT · TOP 40 POSITIONS
| # | Holding | Weight | Price | Day | 52-wk | |
|---|---|---|---|---|---|---|
| 1 | MRNAMODERNA | 13.17% | $223.37 | -3.4% | ||
| 2 | TXG10X GENOMICS | 5.40% | $58.19 | -1.5% | ||
| 3 | TWSTTWIST BIOSCIENCE | 5.54% | $111.60 | -2.3% | ||
| 4 | GHGUARDANT HEALTH | 5.09% | $151.70 | -2.0% | ||
| 5 | ILMNILLUMINA | 4.80% | $207.01 | -1.2% | ||
| 6 | NTRANATERA | 4.53% | $319.09 | -1.2% | ||
| 7 | QGENQIAGEN NV | 3.71% | $49.89 | -0.4% | ||
| 8 | TECHBIO-TECHNE | 3.66% | $72.80 | -0.1% | ||
| 9 | VRTXVERTEX PHARMACEUTICALS | 3.68% | $538.60 | -0.7% | ||
| 10 | BMRNBIOMARIN PHARMACEUTICAL | 3.17% | $57.23 | +0.9% | ||
| 11 | PRAXPRAXIS PRECISION MEDICINES | 3.02% | $328.13 | +1.0% | ||
| 12 | CDNACAREDX | 2.86% | $77.88 | -2.4% | ||
| 13 | BNTXBIONTECH SE | 2.38% | $85.60 | +0.7% | ||
| 14 | LLYELI LILLY | 2.27% | $1443.50 | +1.1% | ||
| 15 | CRSPCRISPR THERAPEUTICS AG | 2.39% | $42.24 | -0.9% |
The full book, free with one sign-in.
Top 15 positions are open to everyone. Sign in once and every fund’s complete holdings — plus watchlists and flow alerts — unlock across the network.
Sign in to see all 50Sector weights
- Healthcare99.69%
- Health Technology99.08%
- Health Services0.75%
- Technology0.31%
- Miscellaneous0.15%
- Other0.06%
Show as table
| Item | Value (%) |
|---|---|
| Healthcare | 99.69% |
| Health Technology | 99.08% |
| Health Services | 0.75% |
| Technology | 0.31% |
| Miscellaneous | 0.15% |
| Other | 0.06% |
Country weights
- United States95.16%
- Hong Kong3.81%
- Germany3.28%
- China3.13%
- Switzerland2.53%
- United Kingdom1.37%
- Netherlands0.94%
- Japan0.59%
Show as table
| Item | Value (%) |
|---|---|
| United States | 95.16% |
| Hong Kong | 3.81% |
| Germany | 3.28% |
| China | 3.13% |
| Switzerland | 2.53% |
| United Kingdom | 1.37% |
| Netherlands | 0.94% |
| Japan | 0.59% |
| 1 week | -5.5% |
| 1 month | -4.1% |
| 3 months | +5.8% |
| 6 months | +39.2% |
| YTD | +35.7% |
| 1 year | +42.8% |
| 3 years | — |
PRICE RETURN, DISTRIBUTIONS NOT REINVESTED
| 1 week | — |
| 1 month | — |
| 3 months | — |
| YTD | — |
| 1 year | — |
CREATION/REDEMPTION DOLLARS, DAILY RECORDS
Monthly net flows
- Inflow / above zero
- Outflow / below zero
Show as table
| Label | Value ($) |
|---|---|
| Nov | −$22.4K |
| Dec | −$20M |
| Jan | −$11.8M |
| Feb | $3.2K |
| Mar | $42M |
| Apr | −$194.5K |
| May | $196.3K |
| Jun | −$177.1K |
| Jul | −$74.6M |
| Aug | $172.3K |
The top holding is 13.2% of the book; the top ten carry 53%. Spread across 52+ names, it behaves like roughly 23 equally-weighted positions.
VOLATILITY & DRAWDOWN FROM THE DAILY TAPE · CONCENTRATION FROM THE LATEST DISCLOSED BOOK
| Most-traded holdings, options premium | Bullish | Bearish |
|---|---|---|
| LLY ELI LILLY | $36M | $37M |
| MRNA MODERNA | $29M | $32M |
| GH GUARDANT HEALTH | $733,086 | $2M |
| GILD GILEAD SCIENCES | $1M | $992,609 |
| BMY BRISTOL MYERS SQUIBB | $1M | $1M |
TODAY’S OPTIONS PREMIUM IN THE FUND’S UNDERLYING NAMES
Due diligence cuts both ways. These funds sit on the same shelf and beat GNOM on at least one dimension that matters — the fee, the asset base, or where the money is going.
| Fund | Fee | Assets | Flow, 1M | The case | |
|---|---|---|---|---|---|
| IVV iShares Core S&P 500 ETF | 0.03% | $879.1B | +$10.1B | -47bp on fee · 10383× the assets · +$10.1B in over the month | Head-to-head |
| SPDW SPDR Portfolio Developed World ex-US ETF | 0.03% | $41.6B | +$917M | -47bp on fee · 492× the assets · +$917M in over the month | Head-to-head |
| BBUS JPMorgan BetaBuilders U.S. Equity ETF | 0.02% | $9.7B | +$356M | -48bp on fee · 115× the assets · +$356M in over the month | Head-to-head |
| SPMD State Street SPDR Portfolio S&P 400 Mid Cap ETF | 0.03% | $18.4B | +$199M | -47bp on fee · 217× the assets · +$199M in over the month | Head-to-head |
| SPTM State Street SPDR Portfolio S&P 1500 Composite Stock Market ETF | 0.03% | $14.2B | +$235M | -47bp on fee · 168× the assets · +$235M in over the month | Head-to-head |